{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:21Z","timestamp":1792205001314,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009906","name":"Wholesaler A V Lykfeldt and Wife's Scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009906","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120736","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T15:59:06Z","timestamp":1763827146000},"page":"120736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum placental growth factor: Pre-analytical stability, comparison of blood derivates and interference from biotin and hemolysis"],"prefix":"10.1016","volume":"580","author":[{"given":"Mette Tiedemann","family":"Skipper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Parkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette Ladeg\u00e5rd","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy Soendersoe","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10022","key":"10.1016\/j.cca.2025.120736_bb0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cca.2025.120736_bb0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/uog.23693","article-title":"Prediction of preterm pre-eclampsia according to NICE and ACOG criteria: descriptive study of 597492 Danish births from 2008 to 2017","volume":"58","author":"Rode","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.cca.2025.120736_bb0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2025.120736_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"19","key":"10.1016\/j.cca.2025.120736_bb0025","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","article-title":"Preeclampsia","volume":"386","author":"Magee","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cca.2025.120736_bb0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cca.2025.120736_bb0035","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/uog.27462","article-title":"Screening for pre-eclampsia with competing-risks model using placental growth factor measurement in blood samples collected before 11 weeks\u2019 gestation","volume":"63","author":"Riishede","year":"2024","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.cca.2025.120736_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn. Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120736_bb0045","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.cca.2025.120736_bb0050","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/uog.26183","article-title":"Pre-eclampsia screening in Denmark (PRESIDE): national validation study","volume":"61","author":"Riishede","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.cca.2025.120736_bb0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.preghy.2017.12.009","article-title":"Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B\u00b7R\u00b7a\u00b7H\u00b7M\u00b7S KRYPTOR compact plus automated immunoassay platform","volume":"11","author":"Chan","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"12","key":"10.1016\/j.cca.2025.120736_bb0060","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/pd.2894","article-title":"Stability of first trimester placental growth factor in serum and whole blood","volume":"31","author":"Cowans","year":"2011","journal-title":"Prenat. Diagn."},{"issue":"12","key":"10.1016\/j.cca.2025.120736_bb0065","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3109\/14767051003678242","article-title":"Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women","volume":"23","author":"Law","year":"2010","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.cca.2025.120736_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2019.08.001","article-title":"Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma","volume":"86","author":"Rowson","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.cca.2025.120736_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114729","article-title":"Analytical validation of a novel panel of biomarkers for a test for preeclampsia","volume":"214","author":"Hendershot","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.cca.2025.120736_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/cclm-2020-0061","article-title":"The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) working Group for the Preanalytical Phase (WG-PRE)","volume":"59","author":"Cornes","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120736_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinchem\/39.2.263","article-title":"Homocysteine and other thiols in plasma and urine: automated determination and sample stability","volume":"39","author":"Fiskerstrand","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2025.120736_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cca.2021.02.022","article-title":"Circulating calprotectin as biomarker in neutrophil-related inflammation: pre-analytical recommendations and reference values according to sample type","volume":"517","author":"Mylemans","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2025.120736_bb0095","article-title":"Preanalytical stability of plasma biomarkers for Alzheimer\u2019s disease pathology","volume":"15","author":"Sunde","year":"2023","journal-title":"Alzheimers Dement (Amst)."},{"issue":"4","key":"10.1016\/j.cca.2025.120736_bb0100","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1111\/bjh.15908","article-title":"Leucocytosis-induced plasma hyperkalaemia in samples conveyed by a pneumatic transport system: tips and tricks","volume":"186","author":"Grzych","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.cca.2025.120736_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/00365513.2021.2003854","article-title":"Biotin interference in routine IDS-iSYS immunoassays for aldosterone, renin, insulin-like growth factor 1, growth hormone and bone alkaline phosphatase","volume":"82","author":"Knudsen","year":"2022","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"5","key":"10.1016\/j.cca.2025.120736_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/00365513.2022.2092901","article-title":"Plasma calprotectin - preanalytical stability and interference from hemolysis","volume":"82","author":"Blavnsfeldt","year":"2022","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"6","key":"10.1016\/j.cca.2025.120736_bb0115","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1515\/cclm-2016-0606","article-title":"False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.cca.2025.120736_bb0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.2020.8144","article-title":"Trends in daily use of biotin supplements among US adults, 1999-2016","volume":"324","author":"Li","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.cca.2025.120736_bb0125","series-title":"User Verification of Presicion and Estimation of Bias; Approved Guideline","author":"Wayne","year":"2014"},{"key":"10.1016\/j.cca.2025.120736_bb0130","series-title":"CLSI guideline EP07","article-title":"Interference testing in clinical chemistry","author":"Wayne","year":"2018"},{"issue":"4","key":"10.1016\/j.cca.2025.120736_bb0135","first-page":"247","article-title":"Population pharmacokinetics of exogenous biotin and the relationship between biotin serum levels and in vitro immunoassay interference","volume":"2","author":"Grimsey","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.cca.2025.120736_bb0140","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1517\/17425255.2016.1136288","article-title":"Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis","volume":"12","author":"Peyro Saint Paul","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.cca.2025.120736_bb0145","series-title":"Product Insert","article-title":"BRAMS PlGF plus Kryptor","author":"Scientific","year":"2018"},{"issue":"3","key":"10.1016\/j.cca.2025.120736_bb0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/00365513.2024.2340037","article-title":"Stability of serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase 1 (sFlt-1)","volume":"84","author":"Lian","year":"2024","journal-title":"Scand. J. Clin. Lab. Invest."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:57:52Z","timestamp":1769795872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125006151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"alternative-id":["S0009898125006151"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120736","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum placental growth factor: Pre-analytical stability, comparison of blood derivates and interference from biotin and hemolysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120736"}}